ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
GeoVax Secures Multi-Product License for ProBioGen's AGE1.CR.pIX® Suspension Cell Line to Bolster MVA-Based Vaccine Development
November 06, 2023ProBioGen and GeoVax Labs, announce the signing of a landmark commercial license agreement for ProBioGen's groundbreaking AGE1. -
GeoVax Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly
August 20, 2021GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today presented data from ongoing studies of its preventive vaccine against COVID-19. -
GeoVax Expands Intellectual Property Portfolio
March 09, 2021GeoVax Labs announced the filing of two additional patent applications important to the Company’s key focus on vaccines against SARS-CoV-2 (COVID-19) and cancer immunotherapies.
Pharma Sources Insight January 2025
